23andMe ’s Pharmacogenetic Test Approved by FDA
The FDA has just approved 23andMe’s Personal Genomic Service (PGS) Pharmacogenetic Reports. This marks the first direct-to-consumer test for pharmacogenetics of enzyme variants that may affect the way patients break down medications. Consumers ...
Source: Medgadget - Category: Medical Devices Authors: Ben Ouyang Tags: Diagnostics Genetics News Source Type: blogs
More News: Alpha-1 Antitrypsin Deficiency | Alzheimer's | Bleeding | Cancer | Cancer & Oncology | Celiac Disease | Clinical Trials | Coeliac Disease | Coumadin | Dystonia | G6PD | Gaucher's Disease | Genetics | Health Management | Marketing | Medical Devices | Ovarian Cancer | Ovaries | Parkinson's Disease | Prostate Cancer | Warfarin | Warnings